Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immucor -- Ignore unavailable to you. Want to Upgrade?

To: Mason Barge who wrote (235)	10/16/1998 7:37:00 PM
From: Thomas Kirwin	Respond to of 422

Sales and Earnings Estimates Mason, Your $0.11-$0.12 eps estimate can't be to far off the mark. The only unknown variable is the Gamma acquisition and its effects on earnings or net income. IMHO - Immucor will report increased revenue, sales and earnings for the 2nd quarter ending November 30th. There is a small possibility that acquisition charges or write-offs, if any, associated with Gamma Biologicals may negate the increase during the 2nd quarter. I believe that the 3rd quarter will show a dramatic increase in all categories. Overall - My previous analysis and stock target price projection remains the same. The razor and blades business plan being implemented by Immucor may produce an eps of $0.50-$0.75 within the next eighteen months. This growth and earnings potential translates into a stock target price of $18-$27 at the current pe of 36. The stock price may languish a bit in its trading range of $8.00 - $10.00 until sales announcements are made, analyst coverage is initiated or incremental improvement in revenues and earnings is exhibited. With just 8,111,300 basic and 8,394,906 diluted weighted average shares outstanding it won't take much to move the stock. The recent acquisition could reduce the time it takes to reach my price target range as the original analysis was made exclusive of such an event. Stay tuned! Tom

To: Mason Barge who wrote (235)	11/4/1998 8:53:00 AM
From: Thomas Kirwin	Read Replies (1) \| Respond to of 422

AABB Convention Visit Hello Mason, I visited the AABB Annual Convention exhibitor center yesterday as it is being held in my own back yard of Philadelphia. Time was limited but I did get to see the Immucor and Ortho-Clinical Diagnostics booths. Sure wish I had more time to visit other vendors and identify possible investment oportunities. The trip was well worth the time and money, $50 entrance fee and $12 parking. Can you believe $12 for only 2 hours? A report will follow as soon as I can find the time to collect my thoughts and write them electronically. One thing I can say at this time is that the Immucor convention staff were really pumped-up, excited and positive about their products, progress to date and future prospects. Lastly, the Immucor booth appeared to be drawing the largest crowd of onlookers. Go Immucor! Tom